— Know what they know.
Not Investment Advice

XENT NASDAQ

Intersect ENT, Inc.
1W: +1.5% 1M: +1.1% 3M: +3.1% 1Y: +57.7% 3Y: +8.2% 5Y: +21.6%
$28.24
Last traded 2022-05-12 — delisted
NASDAQ · Healthcare · Medical - Devices

Balance Sheet Trends

Total Assets
$147M -35.4% ▼
5Y CAGR: +2.5%
Total Liabilities
$216M +34.6% ▲
5Y CAGR: +69.6%
Shareholders Equity
-$69M -203.1% ▼
Cash & Investments
$61M -30.7% ▼
5Y CAGR: -10.1%
Total Debt
$142M +120.8% ▲
Net Debt
$104M +104.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$20M$9M$21M$14M$38M
Short-Term Investments$82M$91M$70M$75M$23M
Cash & ST Investments$102M$101M$91M$88M$61M
Net Receivables$17M$20M$19M$15M$17M
Inventory$8M$12M$17M$12M$19M
Other Current Assets$3M$3M$2M$3M$9M
Total Current Assets$130M$135M$129M$118M$106M
Property, Plant & Equip.$5M$6M$18M$23M$20M
Goodwill & Intangibles$0$0$0$68M$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$436K$413K$559K$19M$21M
Total Non-Current Assets$5M$6M$19M$109M$41M
Total Assets$136M$141M$148M$227M$147M
— Liabilities —
Accounts Payable$3M$6M$4M$6M$9M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$14M$14M$15M$38M$48M
Total Current Liabilities$18M$20M$19M$44M$57M
Long-Term Debt$0$0$0$64M$142M
Other Non-Current Liab.$679K$234K$11M$51M$17M
Total Non-Current Liabilities$679K$234K$11M$116M$159M
Total Liabilities$18M$20M$30M$160M$216M
— Equity —
Common Stock$30K$31K$32K$33K$34K
Retained Earnings-$165M-$188M-$231M-$303M-$463M
Accumulated OCI-$92K-$41K$53K$1K-$10K
Total Stockholders Equity$117M$121M$118M$67M-$69M
Total Liabilities & Equity$136M$141M$148M$227M$147M
— Key Metrics —
Total Debt$0$0$11M$64M$142M
Net Debt-$20M-$9M-$10M$51M$104M
Total Investments$82M$91M$70M$75M$23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms